Global Genitourinary Drugs Market Size, Share, Growth, Industry Trends and Forecast 2020-2030

Genitourinary drugs are used for the treatment of disorders related to kidney, urinary bladder, ureters, and urethra. These disorders are mainly caused due to damage to the urinary tract or the genital organs. Genitourinary infections caused by bacteria and yeast may be communicable. Growing incidences of genitourinary infections and cancers in the urinary system are playing a major role in driving the genitourinary drugs market. Genitourinary drugs have substituted the usage of immunosuppressant and steroids used during genitourinary disorders. This is because their consumption resulted in severe side-effects like vomiting, nausea, and diarrhoea. The global Genitourinary drugs market accounted approximate USD 30.4 billion in 2020 and it is expected to reach USD 30.2 billion by 2030 with a CAGR of 0.50% during forecast period.
Download Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Table & Figures) @ https://www.decisionforesight.com/request-sample/DFS020191
Market Dynamics and Factors:
Rising cases of genitourinary disorders, growing cases of urinary cancer, and increasing occurrence of sexually transmitted diseases are the major factors driving the growth of the genitourinary drugs market. For instance, according to the Centre for Disease Control and Prevention (CDC), over 2.3 million Americans in the U.S were diagnosed with sexually transmitted diseases in 2017. Additionally, the increasing awareness regarding impotency and urinary incontinence is also attributing towards the market growth of genitourinary drugs. Technological advancements in drug research and increasing strategic collaborations among major players in the market is expected to create more opportunities for market growth in the coming future. For instance, Bristol-Myers Squibb collaborated with Nektar Therapeutics to assess the collective efficacy of NKTR-214 and Opdivo for treating five types of tumour, and bladder cancer in September 2016. However, certain factors like lack of compliance to medication, rising cases of drug counterfeiting, and drug patent expirations may restrain the market growth of genitourinary drugs in the forecast period. Moreover, the evolution of novel drugs such as Cialis has propelled the growth of the global genitourinary drugs market. Novel drugs are more effective than multiple-therapy drugs and are less costly compared to them. The success of Cialis has intensified further development of novel drugs which in turn has attributed towards the growth of the market.
Market Segmentation:
Global Genitourinary Drugs Market – By Product Type
Urologicals
Hormonal Therapy
Gynaecological
Anti-Infective
Others
Global Genitourinary Drugs Market – By Indication
Prostate Cancer
Ovarian Cancer
Bladder Cancer
Cervical Cancer
Renal Cancer
Erectile Dysfunction
Urinary Tract Infections
Sexually Transmitted Diseases
Haematuria And Others
Global Genitourinary Drugs Market – By End-User
Hospitals
Super-Speciality Centers
Clinics
Others
Global Genitourinary Drugs Market – By Geography
North America
U.S.
Canada
Mexico
Europe
U.K.
France
Germany
Italy
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
Rest of Asia Pacific
ROW
Latin America
Middle East
Africa
New Business Strategies, Challenges & Policies are mentioned in Table of Content, Request TOC at @ https://www.decisionforesight.com/toc-request/DFS020191
Geographic Analysis:
North America is expected to dominate the genitourinary market during the forecast period in terms of market share. The major factors responsible for such domination are high prevalence of major genitourinary disorders and cancers in the region; awareness regarding impotence & urinary incontinence; robust healthcare infrastructure; and presence of major drug manufacturers in the region. Europe is expected to be the second most dominating market for genitourinary drugs during the forecast period. Government investments in healthcare; rising geriatric population leading to chronic urinary diseases; and increased R&D activities in the region are the major factors attributing for the market growth in the European region. The Asia Pacific region is anticipated to witness the fastest growth during the forecast period. Rising disposable incomes leading to increasing demand for genitourinary drugs in APAC region; continuous improvements in healthcare facilities; and high R&D investments by global players in APAC region are the major factors behind the rapid growth of the market in this region.
Competitive Scenario:
The key players operating in the global genitourinary drugs market are –
Pfizer, GlaxoSmithKline, Bristol-Myers Squibb Co., Hoffman-La Roche Inc., Abbott Laboratories, Merck & Co., Novartis AG, Ionis Pharmaceuticals Inc., Antares Pharma, Bayer AG, Allergan, Teva Pharmaceutical Industries Ltd.
Connect to Analyst @ https://www.decisionforesight.com/speak-analyst/DFS020191
How will this Market Intelligence Report Benefit You?
The report offers statistical data in terms of value (US$) as well as Volume (units) till 2030.
Exclusive insight into the key trends affecting the Global Genitourinary Drugs industry, although key threats, opportunities and disruptive technologies that could shape the Global Genitourinary Drugs Market supply and demand.
The report tracks the leading market players that will shape and impact the Global Genitourinary Drugs Market most.
The data analysis present in the Global Genitourinary Drugs Market report is based on the combination of both primary and secondary resources.
The report helps you to understand the real effects of key market drivers or retainers on Global Genitourinary Drugs Market business.
The 2021 Annual Global Genitourinary Drugs Market offers:
100+ charts exploring and analysing the Global Genitourinary Drugs Market from critical angles including retail forecasts, consumer demand, production and more
15+ profiles of top producing states, with highlights of market conditions and retail trends
Regulatory outlook, best practices, and future considerations for manufacturers and industry players seeking to meet consumer demand
Benchmark wholesale prices, market position, plus prices for raw materials involved in Global Genitourinary Drugs Market type
Buy This Premium Research Report@ https://www.decisionforesight.com/checkout/DFS020191
About Us:
Decision Foresight is a market research organization known for its reliable and genuine content, market estimation and the best analysis which is designed to deliver state-of-the-art quality syndicate reports to our customers. Apart from syndicate reports, you will find the best market insights, strategies that will help in taking better business decisions on subjects that may require you to develop and grow your business-like health, science, technology and many more. At Decision Foresight, we truly believe in disseminating the right piece of knowledge to a large section of the audience and cover the in-depth insights of market leaders across various verticals and horizontals.
Contact:
Email: [email protected]
For Latest Update Follow Us:
https://www.facebook.com/Decision-Foresight-110793387201935
https://twitter.com/DecisionFs
https://www.linkedin.com/company/decision-foresight/